Stirlingshire Investments, Inc.
Source: SEC Form 13F · as of Mar 2026Stirlingshire Investments, Inc. holds 14 biotech & pharma companies tracked by BioSniper, totaling $4.1M in value as of Mar 2026 (SEC Form 13F).
Companies held
14
Total value held
$4.1M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 2,406 | $588K |
| MRKMerck & Co., Inc. | 3,108 | $376K |
| UTHRUNITED THERAPEUTICS Corp | 520 | $308K |
| CAHCardinal Health Inc. | 1,426 | $301K |
| MCKMcKesson Corporation | 335 | $290K |
| CORCencora Inc. | 882 | $277K |
| LLYELI LILLY & Co | 299 | $275K |
| AZNASTRAZENECA PLC | 1,377 | $272K |
| INCYIncyte Corp. | 2,773 | $261K |
| PTCTPTC THERAPEUTICS, INC. | 3,718 | $253K |
| NVSNovartis AG | 1,653 | $252K |
| PFEPFIZER INC | 8,658 | $243K |
| ABBVAbbVie Inc. | 950 | $207K |
| EBSEmergent BioSolutions Inc. | 19,285 | $160K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.